Attachment glycoproteins and receptor specificity of rat coronaviruses

Laboratory Animal Science

Volumn 46, Issue 2, 1996, Pages 159-166

  Gagneten, Sara ^a   Scanga, Charles A ^a   Dveksler, Gabriela S ^a   Beauchemin, Nicole ^b   Percy, Dean ^c   Holmes, Kathryn V ^a,d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD66 ANTIGENS; CEACAM2 PROTEIN, MOUSE; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; GLYCOPROTEIN; HEMAGGLUTININ ESTERASE; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS RECEPTOR;

ANIMAL; ARTICLE; C3H MOUSE; CELL LINE; CORONAVIRUS; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; IMMUNOBLOTTING; KIDNEY; METABOLISM; MOUSE; PHYSIOLOGY; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE; CORONAVIRUS, RAT; CRICETINAE; DNA, COMPLEMENTARY; GLYCOPROTEINS; HEMAGGLUTININS, VIRAL; IMMUNOBLOTTING; KIDNEY; MICE; MICE, INBRED C3H; RATS; RECEPTORS, VIRUS; TRANSFECTION; VIRAL FUSION PROTEINS; VIRAL PROTEINS;

EID: 0030124218     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lindsey, J. R. 1986. Prevalence of viral and mycoplasmal infections in laboratory rodents, p. 801-808. In P. N. Bhatt, R. O. Jacoby, H. C. Morse III, et al. (ed.). Viral and mycoplasmal infections of laboratory rodents. Academic Press, Inc., New York.
2. Spaan, W., D. Cavanagh, and M. C. Horzinek. 1988. Coronaviruses: structure and genome expression. J. Gen. Virol. 69:2939-2952.
3. Sawicki, S. G., and D. L. Sawicki. 1990. Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 64:1050-1056.
4. Barthold, S. W. 1986. Mouse hepatitis virus biology and epizootiology. p. 571-601. In P. N. Bhatt, R. O. Jacoby, H. C. Morse III, et al. (ed.), Viral and mycoplasmal infections of laboratory rodents. Effects on biomedical research. Academic Press, Orlando, Fla.
5. Barthold, S. W., D. S. Beck, and A. L. Smith. 1986. Mouse hepatitis virus nasoeneephalopathy is dependent upon virus strain and host genotype. Arch. Virol. 91:247-256.
6. Wege, H., S. Siddell, and V. ter Meulen. 1982. The biology and pathogenesis of coronaviruses. 99:165-200.
7. Williams, R. K., G. S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
8. Nedellec, P., G. S. Dveksler, E. Daniels, et al. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
9. Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, et al. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1-8.
10. Yokomori, K., and M. M. C. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:6194-6199.
11. Coutelier, J-P., C. Godfraind, G. S. Dveksler, et al. 1994. B lymphocyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as receptors for murine coronavirus. Eur. J. Immunol. 24:1383-1390.
12. Jacoby, R. O. 1986. Rat coronavirus, p. 625-638. In P. N. Bhatt, R. O. Jacoby, H. C. Morse, et al. (ed.), Viral and mycoplasmal infections of rodents. Academic Press, Inc., New York.
13. Parker, J. S., S. S. Cross, and W. R. Rowe. 1970. Rat coronavirus (RCV), a prevalent naturally occurring pneumotropic virus of rats. Arch. Gesamte Virusforsch. 31:293-302.
14. Jacoby, R. O., P. N. Bhatt, and A. M. Jonas. 1975. Pathogenesis of sialodacryoadenitis in gnotobiotic rats. Vet. Pathol. 12:196-209.
15. Percy, D. H, and K. L. Williams. 1990. Experimental Parker's coronavirus infection in Wistar rats. Lab. Anim. Sci. 40:603-607.
16. Barthold, S. W., M. S. de Souza, and A. L. Smith. 1990. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab Anim. Sci. 40:481-485.
17. La Regina, M., L. Woods, P. Klender, et al. 1992. Transmission of sialodacryoadenitis virus (SDAV) from infected rats to rats and mice through handling, close contact, and soiled bedding. Lab. Anim. Sci. 42:344-346.
18. Bhatt, P. N., D. Percy, and A. M. Jones. 1972. Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group. J. Infect. Dis. 126:123-130.
19. Hirano, N., H. Takamaru, K. Ono, et al. 1986. Replication of sialodacryoadenitis virus of rat in LBC cell culture. Arch. Virol. 88:121-125.
20. Gaertner, D. J., A. L. Smith, F. X. Paturzo, et al. 1991. Susceptibility of rodent cell lines to rat coronaviruses and differential enhancement by trypsin or DEAE-dextran. Arch. Virol. 118:57-66.
21. Percy, D., S. Bond, and J. MacInnes. 1989. Replication of sialodacryoadenitis virus in mouse L-2 cells. Arch. Virol. 104:323-333.
22. Percy, D. H., K. L. Williams, S. J. Bond, et al. 1990. Characteristics of Parker's rat coronavirus (PRC) replicated in L-Z cells. Arch. Virol. 112:195-202.
23. Sturman, L. S., and K. K. Takemoto. 1972. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect Immun. 6:501-507.
24. Storz, J., R. Rott, and G. Kaluza. 1981. Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment. Infect. Immun. 31:1214-1222.
25. Sturman, L. S., K. V. Holmes, and J. Behnke. 1980. Isolation of coronaviras envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 33:449-462.
26. Vlasak, R., W. Luytjes, J. Leider, et al. 1988. The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J. Virol. 62:4686-4690.
27. Williams, R. K., G-S. Jiang, S. W. Snyder, et al. 1990. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:3817-3823.
28. Arvan, P., R. S. Cameron, and J. D. Castle. 1983. Secretory membranes of the rat parotid gland: preparation and comparative characterization, p. 75-87. In Methods in enzymology vol. 98. Academic Press, Inc., New York.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
30. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, et al. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
31. Hogue, B. G., T. E. Kienzle, and D. A. Brian. 1989. Synthesis and processing of the bovine enteric coronavirus hemagglutinin protein. J. Gen. Virol. 70:345-352.
32. Hogue, B. G., B. King, and D. A. Brian. 1984. Antigenic relationships among proteins of bovine coronavirus, human respiratory coronavirus OC43, and mouse hepatitis coronavirus A59. J. Virol. 51:384-388.
33. Percy, D. H., S. J. Bond, F. X. Paturzo, et al. 1990 Duration of protection from reinfection following exposure to sialodacryoadenitis virus in Wistar rats. Lab. Anim. Care 40:144-149. (Published erratum appears in Lab. Anim. Sci. 41:292).
34. Luytjes, W., P. J. Bredenbeek, A. F. Noten, et al. 1988. Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166:415-422.
35. Sugiyama, K., R. Ishikawa, and N. Fukuhara. 1986. Structural polypeptides of the murine coronavirus DVIM. Arch. Virol. 89:245-254.
36. Yokomori, K., L. R. Banner, and M. M. Lai. 1991. Heterogeneity of gene expression of the hemagglutininesterase (HE) protein of murine coronaviruses. Virology 183:647-657.
37. Gagneten, S., O. Gout, M. Dubois-Dalcq, et al. 1995. Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein. J. Virol. 69:889-895.
38. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
39. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
40. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
41. Boyle, J. F., D. G. Weismiller, and K. V. Holmes. 1987. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:185-189.
42. Drexler, K., J. Dannull, I. Hindennach, et al. 1991. Single mutations in a gene for a tail fiber component of an Escherichia coli phage can cause an extension from a protein to a carbohydrate as a receptor. J. Mol. Biol. 219:655-663.